Adagene
ADAG
$2.55
Share price
4.51%
Change (1 day)
68.87%
Change (1 year)
Categories
Revenue for Adagene (ADAG)
Revenue in 2020 (TTM): $0.87 M
According to Adagene's latest financial reports the company's current revenue (TTM
) is $9.29 M.
In 2022 the company made a revenue of $9.29 M a decrease over the years 2021 revenue that were of $10.17 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Adagene from 2018 to 2020
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 | $9.29 M | -8.67% |
| 2021 | $10.17 M | 1351.71% |
| 2020 | $0.7 M | 46.02% |
| 2019 | $0.48 M | -68.24% |
| 2018 | $1.51 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $0.24 M | -97.40% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $21.83 M | 135.01% | 🇬🇧 UK |
 Novavax NVAX | $0.69 B | 7,362.41% | 🇺🇸 USA |
 Novocure
NVCR | $0.52 B | 5,556.67% | Jersey |